Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

BACKGROUND: To date, there has been no systematic examination of the relationship between international normalized ratio (INR) control measurements and the prediction of adverse events in patients with atrial fibrillation on oral anticoagulation. METHODS AND RESULTS: We searched MEDLINE, EMBASE, an...

Полное описание

Библиографические подробности
Главные авторы:	Wan, Y, Heneghan, C, Perera, R, Roberts, N, Hollowell, J, Glasziou, P, Bankhead, C, Xu, Y
Формат:	Journal article
Язык:	English
Опубликовано:	2008

Схожие документы

Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation statusResearch in context
по: Tommaso Bucci, и др.
Опубликовано: (2024-12-01)

Rhythm control agents and adverse events in patients with atrial fibrillation.
по: Taylor, C, и др.
Опубликовано: (2010)

Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation
по: Anne Pernille Toft-Petersen, и др.
Опубликовано: (2024-01-01)

Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation.
по: Anne Pernille Toft-Petersen, и др.
Опубликовано: (2024-01-01)

Anticoagulant management in patients with atrial fibrillation.
по: Fitzmaurice, D, и др.
Опубликовано: (2009)

Machine Learning Approaches to Predict Major Adverse Cardiovascular Events in Atrial Fibrillation
по: Pedro Moltó-Balado, и др.
Опубликовано: (2024-01-01)

3021 Haemodialysis and atrial fibrillation anticoagulation decisions
по: Stephen Bacchi, и др.
Опубликовано: (2024-08-01)

Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation
по: Ding J, и др.
Опубликовано: (2024-02-01)

Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation
по: Vasco Iten, и др.
Опубликовано: (2024-12-01)

Time trends in atrial fibrillation-associated stroke and premorbid anticoagulation
по: Yiin, G, и др.
Опубликовано: (2018)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
по: I. Yu. Koroleva, и др.
Опубликовано: (2016-11-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
по: Yu. P. Skirdenko, и др.
Опубликовано: (2020-05-01)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
по: Pasquale Santangeli, и др.
Опубликовано: (2011-01-01)

Challenging anticoagulation decisions in atrial fibrillation: a narrative review
по: Michael Griffin, и др.
Опубликовано: (2024-10-01)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
по: Xue Zhou, и др.
Опубликовано: (2020-01-01)

A systematic review of economic aspects of service interventions to increase anticoagulation use in atrial fibrillation
по: Jones, NR, и др.
Опубликовано: (2021)

Underuse of anticoagulation for atrial fibrillation - are we failing our patients?
по: Jones, N, и др.
Опубликовано: (2017)

Atrial fibrillation – NICE 2021 update and the focus on anticoagulation
по: Jones, N, и др.
Опубликовано: (2022)

CURRENT POSSIBILITIES OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION
по: M. Yu. Gilyarov, и др.
Опубликовано: (2015-10-01)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
по: A. S. Gerasimenko, и др.
Опубликовано: (2021-05-01)

Challenges of anticoagulant treatment in atrial fibrillation with liver disease
по: Alina Doina Nicoara, и др.
Опубликовано: (2024-10-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
по: M. V. Serova, и др.
Опубликовано: (2021-09-01)

Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality
по: Łukasz Pyka MD, PhD, и др.
Опубликовано: (2023-12-01)

Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.
по: Heneghan, C, и др.
Опубликовано: (2006)

Sex-specific comparative outcomes between oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
по: Gregory Y H Lip, и др.
Опубликовано: (2024-08-01)

Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
по: Tahmeed Contractor, и др.
Опубликовано: (2011-01-01)

Moderate/severe biatrial dilation predicts adverse events after ablation in atrial fibrillation with heart failure
по: Yan Yao, и др.
Опубликовано: (2024-10-01)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
по: Raffaele De Caterina, и др.
Опубликовано: (2019-03-01)

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS
по: A. А. Sokolova, и др.
Опубликовано: (2017-12-01)

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
по: Jennifer R. Brown, и др.
Опубликовано: (2017-10-01)

Challenges of anticoagulant therapy in patients with atrial fibrillation in clinical practice.
по: Hobbs, R
Опубликовано: (2012)

ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - EXPERT SOFTWARE MAY BE THE ANSWER
по: Fitzmaurice, D, и др.
Опубликовано: (1994)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
по: Z. D. Kobalava, и др.
Опубликовано: (2021-03-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
по: M. Yu. Gilyarov
Опубликовано: (2015-12-01)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
по: Dana Prídavková, и др.
Опубликовано: (2019-01-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
по: D. V. Pevzner, и др.
Опубликовано: (2023-06-01)

Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease
по: N. Sh. Zagidullin, и др.
Опубликовано: (2021-10-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
по: D. A. Itkin, и др.
Опубликовано: (2015-02-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
по: Yu. P. Skirdenko, и др.
Опубликовано: (2019-03-01)

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
по: E. I. Baranova
Опубликовано: (2018-11-01)